2016

10733 bookmarks
Newest
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals - PubMed
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals - PubMed
This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.
·pubmed.ncbi.nlm.nih.gov·
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals - PubMed
BREAKING: 85-Million-Person Study Finds Increased Risks of Stroke, Heart Attack, Coronary Artery Disease, and Arrhythmia Following COVID-19 Vaccination
BREAKING: 85-Million-Person Study Finds Increased Risks of Stroke, Heart Attack, Coronary Artery Disease, and Arrhythmia Following COVID-19 Vaccination
COVID-19 mRNA and viral vector injections linked to stroke (+240%), heart attack (+286%), coronary artery disease (+244%), and arrhythmia (+199%) in large-scale analysis.
·thefocalpoints.com·
BREAKING: 85-Million-Person Study Finds Increased Risks of Stroke, Heart Attack, Coronary Artery Disease, and Arrhythmia Following COVID-19 Vaccination
BIFIDO BUST: YOGURT'S DIRTY SECRET - The HighWire
BIFIDO BUST: YOGURT'S DIRTY SECRET - The HighWire
Gastroenterologist and microbiome expert Dr. Sabine Hazan reveals that many commercial yogurts and probiotics don’t contain the gut-healthy strains they claim, raising major concerns about the yogurt and supplement industry standards. Her cutting-edge research links gut health to chronic disease and vaccine response, pointing to the microbiome as a critical—yet overlooked—piece of the medical puzzle. […]
·thehighwire.com·
BIFIDO BUST: YOGURT'S DIRTY SECRET - The HighWire
Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment - ScienceDirect
Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment - ScienceDirect
Trehalose has been proposed as a possible therapeutic option for attenuating the neuropathological changes associated with neurodegeneration, includin…
·sciencedirect.com·
Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment - ScienceDirect
! ! Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study | Annals of the Rheumatic Diseases
! ! Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study | Annals of the Rheumatic Diseases
Objectives To evaluate the associations of regular glucosamine use with all-cause and cause-specific mortality in a large prospective cohort. Methods This population-based prospective cohort study included 495 077 women and men (mean (SD) age, 56.6 (8.1) years) from the UK Biobank study. Participants were recruited from 2006 to 2010 and were followed up through 2018. We evaluated all-cause mortality and mortality due to cardiovascular disease (CVD), cancer, respiratory and digestive disease. HRs and 95% CIs for all-cause and cause-specific mortality were calculated using Cox proportional hazards models with adjustment for potential confounding variables. Results At baseline, 19.1% of the participants reported regular use of glucosamine supplements. During a median follow-up of 8.9 years (IQR 8.3–9.7 years), 19 882 all-cause deaths were recorded, including 3802 CVD deaths, 8090 cancer deaths, 3380 respiratory disease deaths and 1061 digestive disease deaths. In multivariable adjusted analyses, the HRs associated with glucosamine use were 0.85 (95% CI 0.82 to 0.89) for all-cause mortality, 0.82 (95% CI 0.74 to 0.90) for CVD mortality, 0.94 (95% CI 0.88 to 0.99) for cancer mortality, 0.73 (95% CI 0.66 to 0.81) for respiratory mortality and 0.74 (95% CI 0.62 to 0.90) for digestive mortality. The inverse associations of glucosamine use with all-cause mortality seemed to be somewhat stronger among current than non-current smokers (p for interaction=0.00080). Conclusions Regular glucosamine supplementation was associated with lower mortality due to all causes, cancer, CVD, respiratory and digestive diseases.
·ard.bmj.com·
! ! Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study | Annals of the Rheumatic Diseases
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Nutrition & Diabetes - Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank
·nature.com·
Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank | Nutrition & Diabetes
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15
A big paper was just published on a newly discovered nutritional C15:0 deficiency syndrome, called Cellular Fragility Syndrome. This is a big deal because nutritional deficiency syndromes (like vitamin C deficiency and scurvy, or vitamin D deficiency and rickets) are rarely discovered. This latest paper describes how d
·fatty15.com·
Cellular Fragility Syndrome & C15:0 Deficiency – fatty15